Accès ouvert
2025
conference-abstract
OpenAlex
Iria Bastón‐Rey, Marta Alvarado, B. Suarez, I. Latras-Cortés et autres
Abstract Background Real-world data on the speed of onset of ustekinumab (UST) in patients with ulcerative colitis (UC) are limited. Current information regarding early response in these patients comes from the UNIFI trial. The primary outcome of this study was to evaluate …
es, us
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Iago Rodríguez–Lago, L Cudero, Consuelo Pascual, Alejandro Mínguez et autres
Abstract Background Ulcerative colitis (UC) is a chronic inflammatory disorder characterized by periods of relapse and remission. Current treatment options aim to achieve mucosal healing and sustain long-term remission, yet many patients experience treatment failure. Filgotinib (FIL), a selective JAK1 inhibitor, has …
es
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Rocío Ferreiro Iglesias, L Nieto García, M L De Castro, P Pérez Galindo et autres
Abstract Background Mesalazine suppositories are recommended in guidelines for the induction and maintenance of remission in patients with ulcerative proctitis (UP). Nevertheless, nonadherence can be frequent and the recommended dose of mesalazine suppositories in maintenance treatment remains unknown. The aim of this …
es
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
M Barreiro-de Acosta, L Nieto-Garcia, M Poncela, Mariam Aguas et autres
Abstract Background Phase III trials have demonstrated the efficacy of risankizumab (RZB), this being the first humanized monoclonal IgG1 antibody which targets the interleukin 23 p19 subunit, in Crohn’s disease (CD). However, real-world data with this drug is limited. The aim of …
es
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Mariam Aguas Peris, Juan Francisco, Raquel Vicente, M Barreiro-de Acosta et autres
Abstract Background Data of telemonitoring costs in inflammatory bowel disease (IBD) are scarce and restricted to a few centres. We evaluated healthcare and indirect costs of telemonitoring of IBD compared to standard care after 52 weeks on a nationwide scale. Methods A …
es
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Alina Baz-López, Iria Bastón‐Rey, Eva Martí-Marqués, Cristina Suárez et autres
Abstract Background The influence of Vitamin D (vitD) has been investigated in inflammatory bowel disease (IBD) patients to see how might affect disease activity. VitD is expected to be lower in winter and higher in summer due to sun exposure. The effect …
es
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Uria Shani, Monica State, Bogdan Mateescu, Ana Davidoiu et autres
Abstract Background Perianal involvement affects approximately 20-30% of Crohn’s Disease patients, significantly impairing their quality of life. Anti-tumor necrosis factor-α inhibitors (anti-TNFs) are still the established biological treatment for perianal Crohn's disease (pCD). However, relapse and non-response are frequent and evidence regarding …
il, ro, pt, fr, gb, es, it, cz, pl, hu, gr, hr, ca, be
(code pays fourni par la source)
Accès ouvert
2024
conference-paper
OpenAlex
F Cajade, FJ Toja-Camba, Lorena Rodríguez-Martinez, L Arcía-Quintanilla et autres
Background and Importance Therapeutic drug monitoring in inflammatory bowel disease (IBD) is a useful tool for optimising biologic therapy. The analysis of adalimumab (ADL) concentrations in blood through enzyme-linked immunosorbent assay (ELISA) requires accumulation of samples to make it a cost-efficient technique, …
es, fr
(code pays fourni par la source)
Accès ouvert
2024
conference-abstract
OpenAlex
M V Mauriz Barreiro, Alberto Ruano‐Raviña, Rocío Ferreiro‐Iglesias, Iria Bastón‐Rey et autres
Abstract Background Inflammatory Bowel Diseases (IBD) are a group of pathologies of unknown etiology associated with some environmental factors, only partially identified. The role of indoor radon, a radioactive gas, has not been formally studied and it might play a role on …
es
(code pays fourni par la source)
Accès ouvert
2024
conference-abstract
OpenAlex
M V Mauriz Barreiro, Alberto Ruano‐Raviña, Rocío Ferreiro‐Iglesias, Iria Bastón‐Rey et autres
Abstract Background It is well known that occupational activity can affect health. The association between type of work and Inflammatory Bowel Diseases (IBD) has been studied previously, but the studies on the topic are scarce and they do not have studied the …
es
(code pays fourni par la source)
Accès ouvert
2024
conference-abstract
OpenAlex
M V Mauriz Barreiro, Alberto Ruano‐Raviña, Rocío Ferreiro‐Iglesias, Iria Bastón‐Rey et autres
Abstract Background Inflammatory Bowel Diseases (IBD) are a group of pathologies of unknown etiology associated with some environmental factors, only partially identified. The role of indoor radon, a radioactive gas, has not been formally studied and it might play a role on …
es
(code pays fourni par la source)
Accès ouvert
2024
conference-abstract
OpenAlex
Cristina Suárez, A L Martinez-Rodriguez, D Moreira-Alvarez, I Ardao-Palacios et autres
Abstract Background Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterised by colonic mucosa inflammation. Its clinical course is marked by alternating periods of relapse and remission that impair patients' quality of life. In the last decades, novel therapies have shown …
es
(code pays fourni par la source)